The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System
Open accessAbstract
BACKGROUND: There is an urgent need to determine whether oversulfated chondroitin sulfate (OSCS), a compound contaminating heparin supplies worldwide, is the cause of the severe anaphylactoid reactions that have occurred after intravenous heparin administration in the United States and Germany. METHODS: Heparin procured from the Food and Drug Administration, consisting of suspect lots of heparin associated with the clinical events as well as control lots of heparin, were screened in a blinded fashion both for the presence of OSCS and for any biologic activity that could potentially link the contaminant to the observed clinical adverse events. In vitro assays for the activation of the contact system and the complement cascade were performed. In addition, the ability of OSCS to recapitulate key clinical manifestations in vivo was tested in swine. RESULTS: The OSCS found in contaminated lots of unfractionated heparin, as well as a synthetically generated OSCS reference standard, directly activated the kinin-kallikrein pathway in human plasma, which can lead to the generation of bradykinin, a potent vasoactive mediator. In addition, OSCS induced generation of C3a and C5a, potent anaphylatoxins derived from complement proteins. Activation of these two pathways was unexpectedly linked and dependent on fluid-phase activation of factor XII. Screening of plasma samples from various species indicated that swine and humans are sensitive to the effects of OSCS in a similar manner. OSCS-containing heparin and synthetically derived OSCS induced hypotension associated with kallikrein activation when administered by intravenous infusion in swine. CONCLUSIONS: Our results provide a scientific rationale for a potential biologic link between the presence of OSCS in suspect lots of heparin and the observed clinical adverse events. An assay to assess the amidolytic activity of kallikrein can supplement analytic tests to protect the heparin supply chain by screening for OSCS and other highly sulfated polysaccharide contaminants of heparin that can activate the contact system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A PREALBUMIN ACTIVATOR OF PREKALLIKREIN
Kaplan, A. P., & Austen, K. F. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.4.696 · Cited by 348
Self-citationActivation of the classical pathway of complement by Hageman factor fragment.
Ghebrehiwet, B., Silverberg, M., & Kaplan, A. P. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.3.665 · Cited by 252
Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate.
Silverberg, M., Dunn, J. T., Garen, L., & Kaplan, A. P. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79699-7 · Cited by 226
Henry, S. P., Giclas, P. C., Leeds, J., Pangburn, M., Auletta, C., Levin, A. A., & Kornbrust, D. J. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36667-4 · Cited by 204
Hojima, Y., Cochrane, C., Wiggins, R., Austen, K., & Stevens, R. (1984) · Blood · doi:10.1182/blood.v63.6.1453.1453 · Cited by 162
Self-citationThe activation of the alternative pathway C3 convertase by human plasma kallikrein.
DiScipio, R. G. (1982) · PubMed · Cited by 115
Wiggins, R. C., Giclas, P. C., & Henson, P. M. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.153.6.1391 · Cited by 101
Silverberg, M., & Diehl, S. V. (1987) · Biochemical Journal · doi:10.1042/bj2480715 · Cited by 66
Verhamme, I. M., BOCK, P. E., & Jackson, C. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313962200 · Cited by 46
Direct induction of complement activation by pharmacologic activation of plasminogen
Schaiff, W. T., & Eisenberg, P. R. (1997) · Coronary Artery Disease · doi:10.1097/00019501-199701000-00002 · Cited by 35
Effect of Heparin on the Activation of Factor XII and the Contact System in Plasma
Pixley, R. A., Cassello, A., Cadena, R. A. D. L., Kaufman, N., & Colman, R. W. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646456 · Cited by 35
Cited by
World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis
Simons, F. E. R., Ardusso, L. R. F., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., Sanchez-Borges, M., Senna, G. E., Sheikh, A., & Thong, B. Y. (2011) · World Allergy Organization Journal · doi:10.1097/wox.0b013e318211496c · Cited by 973
Drug Allergy: An Updated Practice Parameter
(2010) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.08.002 · Cited by 957
The diagnosis and management of anaphylaxis practice parameter: 2010 Update
Lieberman, P., Nicklas, R. A., Oppenheimer, J., Kemp, S. F., Lang, D. M., Bernstein, D. I., Bernstein, J. A., Burks, A. W., Feldweg, A. M., Fink, J. N., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.022 · Cited by 739
World Allergy Organization anaphylaxis guidelines: Summary
Simons, F. E. R., Ardusso, L. R. F., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., Sanchez-Borges, M., Senna, G. E., Sheikh, A., & Thong, B. Y. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.038 · Cited by 570
How it all starts: Initiation of the clotting cascade
Smith, S. A., Travers, R. J., & Morrissey, J. H. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1050550 · Cited by 529
Self-citation
Metadata
- Authors
- Kishimoto, T. K., Viswanathan, K., Ganguly, T., Elankumaran, S., Smith, S., Pelzer, K., Lansing, J. C., Sriranganathan, N., Zhao, G., Galcheva-Gargova, Z., Al-Hakim, A., Bailey, G. S., Fraser, B., Roy, S., Rogers-Cotrone, T., Buhse, L., Whary, M., Fox, J., Nasr, M., Dal Pan, G. J., Shriver, Z., Langer, R. S., Venkataraman, G., Austen, K. F., Woodcock, J., & Sasisekharan, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-06-05
- Volume
- 358
- Issue
- 23
- Pages
- 2457-2467
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2081848037
- Cited by
- 621
- References
- 11
- FWCI
- 34.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.